Trends in immune checkpoint inhibitor related myocarditis: A decade of insights
The increasing incidence of ICIrM likely reflects improved clinical awareness and diagnostic practices. Continued efforts to optimize surveillance, early detection, and mitigation strategies are essential as ICI use expands globally.
Authors
- Isabel G. Scalia (ORCID: https://orcid.org/0000-0002-6459-9767)
- Mohammed Tiseer Abbas
- Joerg Herrmann
- Reza Arsanjani
- Milagros Pereyra Pietri
- Juan M. Farina
- Ahmed K. Mahmoud
- Kamal Awad
- Chadi Ayoub
- Cecilia Tagle-Cornell
Institutions
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- International Journal of Cardiology
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1016/j.ijcard.2026.134189
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00